Related Experiment Videos

Animal testing of retroviral-mediated gene therapy for factor VIII deficiency

J S Greengard¹, D J Jolly

¹Chiron Technologies Department of Vaccines and Gene Therapy, Emeryville, CA 94608, USA. judith_greengard@cc.chiron.com

Thrombosis and Haemostasis

|December 22, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model.

Cancer gene therapy·2013

Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model.

Cancer gene therapy·2013

American Society of Hematology--40th annual meeting. 4-8 December 1998, Miami Beach, FL, USA.

IDrugs : the investigational drugs journal·2005

Toxicity assessment of intratumoral injection of the herpes simplex type I thymidine kinase gene delivered by retrovirus in patients with refractory cancer.

Molecular therapy : the journal of the American Society of Gene Therapy·2001

Factors affecting long-term expression of a secreted transgene product after intravenous administration of a retroviral vector.

Molecular therapy : the journal of the American Society of Gene Therapy·2001

Analysis of testes and semen from rabbits treated by intravenous injection with a retroviral vector encoding the human factor VIII gene: no evidence of germ line transduction.

Human gene therapy·2000

See all related articles